139 related articles for article (PubMed ID: 19657365)
21. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
[TBL] [Abstract][Full Text] [Related]
22. Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis.
Choe J; Kim HS; Zhang X; Armitage RJ; Choi YS
J Immunol; 1996 Aug; 157(3):1006-16. PubMed ID: 8757604
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
24. Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Apr; 7(4):618-24. PubMed ID: 8464239
[TBL] [Abstract][Full Text] [Related]
25. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
26. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
[TBL] [Abstract][Full Text] [Related]
28. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells.
Huang RW; Tsuda H; Takatsuki K
Int J Hematol; 1993 Aug; 58(1-2):83-92. PubMed ID: 8219114
[TBL] [Abstract][Full Text] [Related]
30. Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo.
Purroy N; Abrisqueta P; Carabia J; Carpio C; Palacio C; Bosch F; Crespo M
Oncotarget; 2015 Apr; 6(10):7632-43. PubMed ID: 25544766
[TBL] [Abstract][Full Text] [Related]
31. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro.
Panayiotidis P; Jones D; Ganeshaguru K; Foroni L; Hoffbrand AV
Br J Haematol; 1996 Jan; 92(1):97-103. PubMed ID: 8562418
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
[TBL] [Abstract][Full Text] [Related]
33. Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.
Ghamlouch H; Darwiche W; Hodroge A; Ouled-Haddou H; Dupont S; Singh AR; Guignant C; Trudel S; Royer B; Gubler B; Marolleau JP
Oncotarget; 2015 Jul; 6(21):18484-503. PubMed ID: 26050196
[TBL] [Abstract][Full Text] [Related]
34. CD62L as a therapeutic target in chronic lymphocytic leukemia.
Burgess M; Gill D; Singhania R; Cheung C; Chambers L; Renyolds BA; Smith L; Mollee P; Saunders N; McMillan NA
Clin Cancer Res; 2013 Oct; 19(20):5675-85. PubMed ID: 23948971
[TBL] [Abstract][Full Text] [Related]
35. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia.
Granziero L; Ghia P; Circosta P; Gottardi D; Strola G; Geuna M; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
Blood; 2001 May; 97(9):2777-83. PubMed ID: 11313271
[TBL] [Abstract][Full Text] [Related]
36. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.
Mainou-Fowler T; Copplestone JA; Prentice AG
J Clin Pathol; 1995 May; 48(5):482-7. PubMed ID: 7629299
[TBL] [Abstract][Full Text] [Related]
37. Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro.
Grdisa M
Leuk Res; 2003 Oct; 27(10):951-6. PubMed ID: 12860016
[TBL] [Abstract][Full Text] [Related]
38. Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?
Filip AA; Ciseł B; Koczkodaj D; Wąsik-Szczepanek E; Piersiak T; Dmoszyńska A
Blood Cells Mol Dis; 2013 Apr; 50(4):263-70. PubMed ID: 23313631
[TBL] [Abstract][Full Text] [Related]
39. Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells.
Lagneaux L; Delforge A; De Bruyn C; Bernier M; Bron D
Leuk Lymphoma; 1999 Nov; 35(5-6):445-53. PubMed ID: 10609782
[TBL] [Abstract][Full Text] [Related]
40. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]